diarrhea

(redirected from Traveler's diarrhea)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for diarrhea

References in periodicals archive ?
Coverage of the Traveler's Diarrhea pipeline on the basis of route of administration and molecule type.
Ceftriaxone also showed low levels of resistance, but this agent is not practical to use for traveler's diarrhea, since it can only be given intramuscularly or intravenously.
Many people in other parts of the world, particularly Europeans, are firm believers in using probiotics to ward off traveler's diarrhea, but Americans are just catching on to the concept of probiotics in general.
The combination zapped the thing rapidly and cured it, so we think it's probably the optimal way to manage traveler's diarrhea," said Dr.
as a cause of traveler's diarrhea and to analyze the species' geographic distribution, clinical features, and susceptibility to antimicrobial agents.
In this study, ulifloxacin's activity against eight pathogens known to cause traveler's diarrhea was compared to the activity of four commonly prescribed antibiotics: ciprofloxacin, rifaximin, ampicillin and co-trimoxazole.
We believe we've shown that rifaximin's properties make it an ideal drug to prevent traveler's diarrhea, and it may be safe for prolonged use," said Dr.
histolytica can usually plead innocent to the charge most frequent leveled against it -- causing traveler's diarrhea.
Wednesday, September 19 from 12:15pm-1:15pm Central Time Presentation number: E-1638 In Vitro Activity of Ulifloxacin Tested against a Worldwide Collection of Pathogens Producing Traveler's Diarrhea
Such forward-looking statements include statements about the ability of Iomai's ETEC vaccine to mitigate the severity of ETEC or otherwise avoid traveler's diarrhea, the expectation that the protective effects shown in this trial would be amplified in the field or Iomai's ability to launch a Phase 3 trial in the next year.
In their search for the wellsprings of traveler's diarrhea, they studied tabletop condiments (green and red hot sauces, guacamole, and pico de gallo) from restaurants in Guadalajara, Mexico, and in Houston.
Traveler's diarrhea is the most frequent health problem abroad (1,2).
Lactobacillus GG has been researched for its effectiveness in managing a variety of conditions including antibiotic-associated diarrhea, traveler's diarrhea, immune system support, Clostridium difficile and atopic eczema, among others.
This allows us to continue our efforts to develop the first-ever vaccine for traveler's diarrhea in the United States and a needle-free influenza vaccine patch that would be simpler to administer than injectable vaccines.